Copyright Reports & Markets. All rights reserved.

Global Post Herpetic Neuralgia Therapies

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Post Herpetic Neuralgia Therapies Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Drugs
      • 1.4.3 Patches
      • 1.4.4 Steroid Injectable
    • 1.5 Market by Application
      • 1.5.1 Global Post Herpetic Neuralgia Therapies Market Share by Application (2014-2025)
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Online Pharmacies
      • 1.5.4 Retail Pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Post Herpetic Neuralgia Therapies Market Size
    • 2.2 Post Herpetic Neuralgia Therapies Growth Trends by Regions
      • 2.2.1 Post Herpetic Neuralgia Therapies Market Size by Regions (2014-2025)
      • 2.2.2 Post Herpetic Neuralgia Therapies Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Post Herpetic Neuralgia Therapies Market Size by Manufacturers
      • 3.1.1 Global Post Herpetic Neuralgia Therapies Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Post Herpetic Neuralgia Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.2 Post Herpetic Neuralgia Therapies Key Players Head office and Area Served
    • 3.3 Key Players Post Herpetic Neuralgia Therapies Product/Solution/Service
    • 3.4 Date of Enter into Post Herpetic Neuralgia Therapies Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Post Herpetic Neuralgia Therapies Market Size by Type (2014-2019)
    • 4.2 Global Post Herpetic Neuralgia Therapies Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Post Herpetic Neuralgia Therapies Market Size (2014-2019)
    • 5.2 Post Herpetic Neuralgia Therapies Key Players in United States
    • 5.3 United States Post Herpetic Neuralgia Therapies Market Size by Type
    • 5.4 United States Post Herpetic Neuralgia Therapies Market Size by Application

    6 Europe

    • 6.1 Europe Post Herpetic Neuralgia Therapies Market Size (2014-2019)
    • 6.2 Post Herpetic Neuralgia Therapies Key Players in Europe
    • 6.3 Europe Post Herpetic Neuralgia Therapies Market Size by Type
    • 6.4 Europe Post Herpetic Neuralgia Therapies Market Size by Application

    7 China

    • 7.1 China Post Herpetic Neuralgia Therapies Market Size (2014-2019)
    • 7.2 Post Herpetic Neuralgia Therapies Key Players in China
    • 7.3 China Post Herpetic Neuralgia Therapies Market Size by Type
    • 7.4 China Post Herpetic Neuralgia Therapies Market Size by Application

    8 Japan

    • 8.1 Japan Post Herpetic Neuralgia Therapies Market Size (2014-2019)
    • 8.2 Post Herpetic Neuralgia Therapies Key Players in Japan
    • 8.3 Japan Post Herpetic Neuralgia Therapies Market Size by Type
    • 8.4 Japan Post Herpetic Neuralgia Therapies Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Post Herpetic Neuralgia Therapies Market Size (2014-2019)
    • 9.2 Post Herpetic Neuralgia Therapies Key Players in Southeast Asia
    • 9.3 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Type
    • 9.4 Southeast Asia Post Herpetic Neuralgia Therapies Market Size by Application

    10 India

    • 10.1 India Post Herpetic Neuralgia Therapies Market Size (2014-2019)
    • 10.2 Post Herpetic Neuralgia Therapies Key Players in India
    • 10.3 India Post Herpetic Neuralgia Therapies Market Size by Type
    • 10.4 India Post Herpetic Neuralgia Therapies Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Post Herpetic Neuralgia Therapies Market Size (2014-2019)
    • 11.2 Post Herpetic Neuralgia Therapies Key Players in Central & South America
    • 11.3 Central & South America Post Herpetic Neuralgia Therapies Market Size by Type
    • 11.4 Central & South America Post Herpetic Neuralgia Therapies Market Size by Application

    12 International Players Profiles

    • 12.1 Endo Pharmaceuticals
      • 12.1.1 Endo Pharmaceuticals Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Post Herpetic Neuralgia Therapies Introduction
      • 12.1.4 Endo Pharmaceuticals Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
      • 12.1.5 Endo Pharmaceuticals Recent Development
    • 12.2 Depomed
      • 12.2.1 Depomed Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Post Herpetic Neuralgia Therapies Introduction
      • 12.2.4 Depomed Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
      • 12.2.5 Depomed Recent Development
    • 12.3 Acorda Therapeutics
      • 12.3.1 Acorda Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Post Herpetic Neuralgia Therapies Introduction
      • 12.3.4 Acorda Therapeutics Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
      • 12.3.5 Acorda Therapeutics Recent Development
    • 12.4 Pfizer
      • 12.4.1 Pfizer Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Post Herpetic Neuralgia Therapies Introduction
      • 12.4.4 Pfizer Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
      • 12.4.5 Pfizer Recent Development
    • 12.5 Mylan
      • 12.5.1 Mylan Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Post Herpetic Neuralgia Therapies Introduction
      • 12.5.4 Mylan Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
      • 12.5.5 Mylan Recent Development
    • 12.6 Daiichi Sankyo
      • 12.6.1 Daiichi Sankyo Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Post Herpetic Neuralgia Therapies Introduction
      • 12.6.4 Daiichi Sankyo Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
      • 12.6.5 Daiichi Sankyo Recent Development
    • 12.7 Teikoku Pharma
      • 12.7.1 Teikoku Pharma Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Post Herpetic Neuralgia Therapies Introduction
      • 12.7.4 Teikoku Pharma Revenue in Post Herpetic Neuralgia Therapies Business (2014-2019)
      • 12.7.5 Teikoku Pharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
      In 2018, the global Post Herpetic Neuralgia Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Post Herpetic Neuralgia Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Post Herpetic Neuralgia Therapies development in United States, Europe and China.

      The key players covered in this study
      Endo Pharmaceuticals
      Depomed
      Acorda Therapeutics
      Pfizer
      Mylan
      Daiichi Sankyo
      Teikoku Pharma
      ...

      Market segment by Type, the product can be split into
      Drugs
      Patches
      Steroid Injectable

      Market segment by Application, split into
      Hospital Pharmacies
      Online Pharmacies
      Retail Pharmacies

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Post Herpetic Neuralgia Therapies status, future forecast, growth opportunity, key market and key players.
      To present the Post Herpetic Neuralgia Therapies development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Post Herpetic Neuralgia Therapies are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now